Serine and threonine phosphorylation has been shown to downregulate insulin signaling at multiple steps, including the receptor and downstream molecules such as insulin receptor substrate-1 (IRS-1). To further address the mechanism of this regulation at the level of IRS-1, we constructed a double serine mutant of IRS-1: S662A/ S731A-IRS-1. The serines 662 and 731 mutated to alanine are surrounding tyrosines Y658 and Y727, respectively. These tyrosines are comprised in YXXM motifs, which are potential binding sites for the p85␣ regulatory subunit of phosphatidylinositol (PI) 3-kinase. In a first series of experiments using the yeast two-hybrid system, we show that IRS-1 interacts with p85␣, and this interaction depends on tyrosine phosphorylation, as shown with the IRS-1 mutant F18 and 3Y-IRS-1. F18-IRS-1 contains 18 potential tyrosine phosphorylation sites mutated to phenylalanine; three of them, i.e. Y608, 628, and 658, which are potential binding sites for p85␣, have been added back in the 3Y-IRS-1 mutant. The tyrosine phosphorylation of IRS-1, which is required for the interaction with p85␣, is thought to occur via endogenous yeast kinases that phosphorylate IRS-1 at least on these PI 3-kinase-binding sites.
I NSULIN binding to its receptor ␣-subunits activates the tyrosine kinase activity of the ␤-subunits, which allows subsequent tyrosine phosphorylation of receptor substrates such as Shc, insulin receptor substrate-1 (IRS-1), IRS-2, IRS-3, and IRS-4 (1-3). The IRS proteins then become docking molecules that interact via their phosphorylated tyrosines with SH2 domain-containing effectors, leading to the biological effects of the hormone (4 -6) .
In addition to its tyrosine phosphorylation, IRS-1 is found to be heavily phosphorylated on serine residues in intact cells. Mounting evidence indicates that serine phosphorylation could negatively regulate insulin action. For example, we and others have reported that in various insulin-sensitive cells, okadaic acid and angiotensin II are able to induce IRS-1 serine and threonine phosphorylation, which correlates with a decrease in IRS-1 tyrosine phosphorylation and a subsequent decrease in IRS-1/p85 association and IRS-1-associated phosphatidylinositol (PI) 3-kinase upon insulin stimulation (7) (8) (9) . In 3T3-F442A adipocytes, tumor necrosis factor-␣ has also been shown to induce IRS-1 serine phosphorylation (10) . This serine-phosphorylated IRS-1 is thought to interact differently with the insulin receptor (IR) compared with wild-type IRS-1 (WT-IRS-1), resulting in inhibition of IR tyrosine kinase activity. It was recently shown in CHO cells that in the absence of growth factor or insulin, glycogen synthase kinase-3 (GSK-3) is activated and phosphorylates IRS-1 on serine residues. This is correlated with a decrease in IRS-1 tyrosine phosphorylation and IR tyrosine kinase activity (11) . Moreover, in 293 cells, phorbol 12-myristate 13-acetate (PMA) treatment stimulates mitogen-activated protein (MAP) kinase, which phosphorylates IRS-1 on serine 612, resulting in inhibition of insulin signaling (12, 13) .
Taken together, these data indicate that serine phosphorylation of either the IR or IRS-1 modulates insulin action and is implicated in the negative regulation of hormone signaling. Hence, this process is likely to contribute at least in part to the insulin resistance found in disease states such as obesity and type II diabetes.
To investigate the molecular mechanism underlying the modulation of insulin signaling by IRS-1 serine phosphorylation, we constructed serine mutants of IRS-1 at the level of YXXMSP motifs that are potential binding sites for p85.
These mutants, S612A/S632A-IRS-1 and S662A/S731A-IRS-1, correspond to serine mutated to alanine surrounding tyrosines Y608/Y628 and Y658/Y727, respectively. Expressing these mutants in 293 cells, we found that these potential serine phosphorylation sites are negative regulators of basal and insulin-induced IRS-1-associated PI-3 kinase activities. Indeed, mutation of these serines increases tyrosine phosphorylation of IRS-1, its binding to p85, and its associated PI 3-kinase activity (8) . PI 3-kinase is a cytosolic enzyme implicated in various cellular functions, such as insulin-induced glucose transport (14) and membrane ruffling (15) . PI 3-kinase is composed of a regulatory subunit of 85 kDa and a catalytic subunit of 110 kDa, which has lipid kinase and serine kinase activities (16, 17) . p85 SH2 domains recognize phosphorylated IRS-1 tyrosine residues in YXXM motifs (18, 19) . Recently, several novel regulatory subunits of PI 3-kinase have been cloned, including 1) p55␣ and p50␣, which are alternatively spliced isoforms of the p85␣ gene; 2) p62 cplx ; and 3) p55
PIK (20 -23) . Compared with p85, p55 PIK contains a conserved region with p85 in its C-terminal part comprising two SH2 domains and an inter-SH2 domain, but it lacks several domains in its N-terminus (i.e. Bcr, SH3, and one proline-rich domain) that are replaced by a 34-amino acid sequence. In the present study we used the yeast two-hybrid system to examine the interaction of p85␣ and p55 PIK with IRS-1. In this system we investigated the importance of IRS-1 tyrosine phosphorylation using IRS-1 tyrosine mutants (F18 and 3Y) with or without coexpression of the IR. Using the IRS-1 serine mutant S662A/S731A, we also determined whether the interaction of IRS-1 with the regulatory subunits of PI 3-kinase could be modulated by serine sites. Finally, we show in intact 293 cells that overexpression of the S662A/ S731A-IRS-1 mutant increases the basal activity of protein kinase B (PKB) compared with that of WT-IRS-1. Taken together, our data indicate that IRS-1 serines 662 and 731 could play an important role in modulating downstream effectors of IRS-1, and hence insulin action.
Materials and Methods Materials
Yeast strain L40 (MATa, Trp 1 , Leu 2 , His 3 , Lys 2 ::lexA-His 3 , URA3: lexA-lacZ) and yeast two-hybrid expression vector pBTM116 (pLex) were provided by A. Vojtek (Seattle, WA); the plasmid pACTII was provided by S. Elledge (Houston, TX). Full-length p85␣ complementary DNA (cDNA) into the pGBT9 vector was a gift from J. E. Pessin (Iowa City, IA). Oligonucleotides were purchased from Eurogentec (Seraing, Belgium), restriction enzymes were obtained from New England Biolabs, Inc. (Beverly, MA), Pwo DNA polymerase was obtained from Boehringer Mannheim (Meylan, France), and synthetic defined dropout yeast media lacking the appropriate amino acids were purchased from BIO-101 (La Jolla, CA). Cell culture media and geneticin were purchased from Life Technologies, Inc. (Paisley, Scotland). All chemical reagents used were obtained from Sigma Chemical Co., Inc. (St. Louis, MO), except protein A-Sepharose, which was obtained from Pharmacia Biotech, Inc. (Uppsala, Sweden); 2-mercaptoethanol and 3-aminophtalhydrazide were purchased from Fluka (Buchs, Switzerland). Antibodies to IRS-1 for immunoprecipitation and Western blotting were raised to the Cterminal (1223-1235) peptide of rat IRS-1.
Plasmid constructions
WT-IRS-1 cDNA and IRS-1 mutants F18, 3Y, and S662A/S731A cDNAs (8, 24) were subcloned in-frame into the pACTII vector using convenient restriction sites, yielding GAD-WT-IRS-1, GAD-F18-IRS-1,  and GAD-3Y-IRS-1, GAD-S662A/S731A-IRS-1 fusion proteins, respectively. Full-length p55 PIK cDNA was amplified by PCR using the following primers: sense, 5Ј-ccggaattcgaccgcgatgacgcagactg-3Ј; and antisense, 5Ј tcccccgggttatctgcagagcgtaggc-3Ј. Then the fragment was subcloned in-frame into the polylinker of pBTM116 using the EcoRI (5Ј-side) and SmaI (3Ј-side) restriction sites. The fusion protein obtained (LexA-p55 PIK ) corresponded to the LexA DNA binding domain (1-147) fused to p55 PIK . LexA-p85␣ was obtained by PCR amplification of p85␣ cDNA using the following set of primers: sense, 5Ј-gccgaggggtacgaattccgggcgctg-3Ј; antisense, 5Ј-atcgcctcggatccgcgtacactgggtagg-3Ј, and then subcloning the PCR product in-frame into EcoRI and BamHI sites of pBTM116. Correct in-frame fusion between LexA and p55 PIK or p85␣ cDNA was verified by sequencing with a primer corresponding to a LexA sequence (5Ј-cttcgtcagcagagcttc-3Ј), using the T7 sequencing kit (Pharmacia Biotech).
Constructs encoding hemagglutinin (HA)-tagged PKB in the mammalian expression vector pECE were gifts from Brian Hemmings and have been described previously (25) .
Yeast transformation and reporter gene activity
The yeast strain L40 was cotransformed with pBTM116 and pACTII plasmids expressing hybrid proteins of interest, using the lithium acetate method (26) . L40 were grown for 48 h on plates containing Trp Ϫ , Leu Ϫ complete supplemented (CS) medium to select clones containing both plasmids (pBTM116 and pACTII carry the Trp ϩ and Leu ϩ selection markers, respectively). Suppression of IR␤ gene expression carried on the pBTM116 vector was accomplished by addition of l-methionine (Sigma Chemical Co.) at 20 mm to the medium. The histidine reporter gene was tested by replicating the clones expressing the different sets of plasmids on plates containing CS medium without tryptophan, leucine, and histidine and by growing them at 30 C for 48 h. Double transformants were also assayed for ␤-galactosidase activity, using a color filter assay as previously described (27) or a liquid culture assay. Briefly, three clones of each transformation were grown for 24 h in Trp Ϫ , Leu Ϫ CS medium, then diluted 10-fold in 2 ml of the same CS medium. After 24 h of additional growth, 1 ml of cells was used for determination of OD at 600 nm; 100 -500 l of cells were used for colorimetric assay at 574 nm. Cells were pelleted, resuspended in 500 l Z buffer (60 mm Na 2 HPO 4 , 40 mm NaH 2 PO 4 , 40 mm KCl, and 1 mm MgSO 4 )-25 l chloroform, and vortexed for 15 sec. After a 10-min incubation at 30 C, 100 l of the chromogenic substrate chlorophenol red-␤-d-galactopyranoside at 50 mm were added. The reaction was performed at 30 C, and ␤-galactosidase activity was measured according to Millers' method (28) . One unit of ␤-galactosidase activity was defined as follows: (A 574 ϫ 1000)/[ A 600 ϫ volume (ml) ϫ time (min)].
Protein expression in yeast
Cotransformed yeast on plates expressing hybrid proteins were grown for 10 h at 30 C in 1 ml Trp Ϫ , Leu Ϫ CS medium, then for an additional 12 h in the same medium adjusted to 50 ml. One milliliter of yeast diluted 10-fold was used for OD quantification at 600 nm. The cells were washed in PBS, frozen in nitrogen for 10 min, and placed at Ϫ20 C for another 10 min. Then the cells were lysed on ice for 20 min with buffer A (50 mm HEPES, 150 mm NaCl, 10 mm EDTA, 10 mm Na 4 P 2 O 7 , 2 mm sodium orthovanadate, and 100 mm NaF, pH 7.5) supplemented with 1% (vol/vol) Triton X-100 and protease inhibitors: 100 U/ml aprotinin, 1 mm PhMeSO 2 F (phenylmethylsulfonylfluoride), 20 mm leupeptin, 2 mm pepstatin, and 4 mm benzamidine. Then glass beads (425-600 m; Sigma Chemical Co.) were added, and the tubes were vortexed for 30 sec and maintained on ice. This step was repeated three times. After the tubes were shaken for 20 min at 4 C and centrifuged for 30 min at 13,000 rpm, immunoprecipitation with rabbit polyclonal antibodies to IRS-1 was performed for 2.5 h at 4 C. Samples were washed alternatively five times with buffer A supplemented with 1% (vol/vol) Triton X-100 and buffer A supplemented with 0.2% (vol/vol) Triton X-100, 0.1% (wt/vol) SDS, and 0.5 m NaCl. Samples were resuspended in Laemmli buffer (29) , loaded on 7.5% polyacrylamide gel, and subjected to SDS-PAGE under reducing conditions. Proteins were transferred to an Immobilon membrane (Millipore Corp., Milford, MA). The membrane was blocked with 10 mm Tris-HCl and 140 mm NaCl, pH 7.4, supplemented with 5% (wt/vol) BSA and probed with either rabbit polyclonal antibodies to IRS-1 or a mouse monoclonal antibody to phosphotyrosine, followed by incubation with [
125 I]protein A.
Cell culture and transfection
HA-tagged WT-PKB, WT-IRS-1, and S662A/S731A-IRS-1 were transiently expressed in 293 EBNA cells, which are human embryo kidney cells constitutively expressing the EBNA-1 protein from the Epstein-Barr virus (Invitrogen, San Diego, CA). The cells were cultured in DMEM containing 5% (vol/vol) FCS and 500 g/ml geneticin. Transfection was performed by the calcium phosphate precipitation method of Chen and Okayama (30) (3 g DNA/9.5-cm 2 dish). Eighteen hours after transfection, the calcium phosphate-DNA precipitates were removed, and cells were incubated in DMEM supplemented with 0.2% (wt/vol) BSA for 20 h before the experiment.
Immunoblot, immunoprecipitation, and in vitro kinase assay of PKB
293-EBNA cells were stimulated or not with 10 Ϫ6 m insulin for 5 min and washed in PBS. Then they were lysed in a buffer containing 50 mm HEPES, 150 mm NaCl, 100 mm NaF, 10 mm EDTA, 10 mm Na 4 P 2 O 7 , 2 mm vanadate, 0.5 mm phenylmethylsulfonylfluoride, 100 IU/ml aprotinin, 20 m leupeptin, and 1% (vol/vol) Triton X-100. The lysates were centrifuged at 15,000 ϫ g at 4 C for 15 min, and 90% of each sample was immunoprecipitated using anti-HA antibody (12CA5) coupled to protein G-Sepharose. After 2.5 h, the pellets were washed, and phosphorylation buffer containing 50 mm Tris, 10 mm MgCl 2 , 1 mm dithiothreitol, 5 m ATP, 3.3 Ci [␥-
32 P]ATP, and 30 m Crosstide (Neosystem, Strasbourg, France) as substrate was added. After 30 min at room temperature, the reaction was stopped by spotting 40 l onto Whatman p81 papers, and immersing in 1% (vol/vol) orthophosphoric acid. After three washes, the papers were air-dried, and radioactivity was determined by Cerenkov counting. We subtracted the background obtained from phosphorylation alone. Ten percent of each lysate was analyzed by SDS-PAGE under reducing conditions, and proteins were transferred to an Immobilon membrane (Immobilon polyvinylidene difluoride, Millipore Corp.). The membrane was cut and immunoblotted with antibodies to either IRS-1 or PKB (provided by B. Hemmings and raised against a peptide containing amino acids 469 -480 of PKB), followed by [ 125 I]protein A and autoradiography.
Results

Interaction of p85␣ with IRS-1 in yeast two hybrid system: role of IRS-1 tyrosine phosphorylation
To study the interaction of the regulatory subunits of PI 3-kinase with IRS-1, we used the yeast two-hybrid system. We constructed hybrid proteins containing either the DNAbinding domain of the bacterial repressor LexA or the activation domain of the transcription factor GAL4, fused to p85␣ and IRS-1, respectively. These two hybrid proteins, LexA-p85␣ and GAD-IRS-1, were coexpressed in yeast, and a colorimetric experiment was performed to measure ␤-galactosidase activity, which reflects interaction between the two proteins. As the interaction between IRS-1 and p85␣ depends on IRS-1 tyrosine phosphorylation, we coexpressed IR␤, IRS-1, and p85␣ in yeast. To do so, we constructed a modified pLex vector in which receptor ␤-subunit (IR␤) is under control of a promoter repressible by methionine to increase phosphorylation of IRS-1 (31) . We verified that the IR intracellular region is expressed in the absence of methionine, and that addition of the repressing molecule prevents expression. As negative controls, we coexpressed LexA-p85␣ and GAD-IRS-1 with the unrelated proteins GAD-ras and LexA-lamin, respectively. LexA-p85␣ and GAD-IRS-1 did not induce detectable ␤-galactosidase activity corresponding to nonspecific interaction (data not shown). As shown in Fig.  1 , in the absence of methionine, i.e. when IR␤ was expressed, a 4-fold increase in the interaction between IRS-1 and p85␣ was seen. However, ␤-galactosidase activity due to interac- tion between IRS-1 and p85␣ was also detectable when IR␤ was not expressed, suggesting that 1) yeast may contain tyrosine kinases able to tyrosine phosphorylate IRS-1; or 2) IRS-1 may interact with p85␣ in a phosphotyrosine-independent manner. To further address this issue, we used two IRS-1 mutants, F18 and 3Y. In F18 IRS-1, the 18 tyrosines corresponding to potential phosphorylation sites by IR and insulin-like growth factor I receptor were replaced by phenylalanines. In 3Y Ϫ IRS-1, three tyrosines, i.e. Y608, Y628, and Y658, were added back to F18-IRS-1, resulting in an IRS-1 protein containing only potential binding sites for PI 3-kinase. We first examined the interaction between the WT or IRS-1 mutants and the IR. GAD-F18-IRS-1, GAD-3Y-IRS-1, or GAD-WT-IRS-1 was coexpressed with the IR (LexA-IR␤). This interaction occurs through the PTB domain of IRS-1 and the phosphorylated NPXY 960 of the IR (32). The three IRS-1 molecules interact similarly with IR, suggesting that no major conformational changes due to mutation of tyrosine to phenylalanine residues have occurred, and that the three IRS-1 proteins are similarly expressed and properly folded in yeast. As shown in Fig. 1 , no or weak interaction was seen between F18-IRS-1 and p85␣. Interestingly, interaction between 3Y-IRS-1 and p85␣ was almost completely restored, as 85% of the ␤-galactosidase activity seen with wild-type IRS-1 was obtained. Moreover, this interaction was increased 4-fold when IR␤ was present compared with the interaction in the absence of receptor.
To be sure that differences between the three IRS proteins concerning the interaction with p85␣ were not due to variations in IRS-1 expression but, rather, reflected the tyrosine phosphorylation level, we measured expression of WT, F18, and 3Y-IRS-1 (Fig. 2) . No IRS-1 was detected when yeast was transformed by pACT II alone. Further, F18 and 3Y-IRS-1 mutants were expressed at similar levels as WT-IRS-1. We then determined the phosphorylation state of IRS-1 in yeast in the presence or absence of IR␤. We failed to detect tyrosine phosphorylation when IR␤ expression was repressed (not shown). However, as shown in Fig. 2 (lower panel) , IR␤ expression clearly induced tyrosine phosphorylation of WT-IRS-1. Although F18-IRS-1 was expressed (Fig. 2, upper panel) , no tyrosine phosphorylation was detected, as expected. 3Y-IRS-1 with Y608, 628, and 658 was tyrosine phosphorylated, as shown in Fig. 2 (lower panel) , to a lesser extent than WT-IRS-1, indicating that other tyrosine residues are phosphorylated on WT-IRS-1.
Taking our results together, we conclude that 1) without expression of IR␤, IRS-1 associates with p85␣ in our yeast two-hybrid system; the fact that IR␤ is not required may indicate either that yeast kinases could phosphorylate IRS-1 on PI 3-kinase binding motifs or IRS-1 could interact in a phosphotyrosine-independent manner; 2) this interaction is increased by expression of IR␤ due to increased IRS-1 phosphorylation; and 3) IRS-1 tyrosine phosphorylation by endogenous yeast kinases would occur at specific sites because F18-IRS-1 shows no or weak interaction with p85␣, and 3Y-IRS-1 restored the association with the PI 3-kinase regulatory subunit compared with WT-IRS-1, showing that at least one of the tyrosines, 608, 628, or 658, is phosphorylated and interacts with p85.
Interaction of p55 PIK with IRS-1
Next we tested whether p55 PIK , a PI 3-kinase regulatory subunit different from p85␣, could interact with IRS-1 in the yeast two-hybrid system. Insulin promotes the tyrosine phosphorylation of p55 PIK on residue 341 in intact cells (20) . In CHO/IR cells, insulin stimulates the binding of p55 PIK to IRS-1 and also the PI 3-kinase activity associated to p55 PIK (20, 22) . p55 PIK cDNA was subcloned into pBTM116 vector to obtain the LexA-p55 PIK fusion protein. Then, LexA-p55 PIK or LexA-p85␣ were coexpressed with GAD-WT-IRS-1, GAD-F18-IRS-1, or GAD-3Y-IRS-1, and ␤-galactosidase activity was measured for each cotransformant (Fig. 3) . As the interaction occurs in absence of IR␤ expression, the experiments were performed without IR using the pLex vector, which has no IR␤ cDNA. We found that p85␣ interacts with WT-IRS-1. This interaction strongly decreased with F18-IRS-1. With 3Y-IRS-1 mutant, the interaction with p85␣ was partially restored compared with WT-IRS-1. Similar to p85␣, p55
PIK interacted with GAD-WT-IRS-1, and this interaction was significantly decreased with F18-IRS-1. Finally, GAD-3Y-IRS-1 interacted with p55 PIK , indicating that phosphorylation of the three YXXM binding sites is sufficient to allow for the interaction.
As a whole, our results suggest that like p85␣, p55 PIK is able to interact with WT-IRS-1 in a yeast two-hybrid system. For both PI 3-kinase regulatory subunits, interaction with IRS-1 depends on phosphotyrosines residues. In the absence of IR␤ expression in yeast, we favor the idea that IRS-1 could be phosphorylated on tyrosines comprised in YXXM motifs, FIG. 2 . Expression of different IRS-1 constructs in the yeast twohybrid system. Clones coexpressing LexA-p85␣ and GAD, GAD-IRS-1, GAD-F18-IRS-1, or GAD-3Y-IRS-1 were grown without L-methionine, allowing IR␤ expression, in appropriate medium for 24 h. The cells were then washed with PBS, frozen in nitrogen, placed at Ϫ20 C for 10 min, lysed, and vortexed in the presence of glass beads. The lysates were subjected to immunoprecipitation using anti-IRS-1 antibody. The proteins were resolved by SDS-PAGE before immunoblotting with antibodies to either IRS-1 or phosphotyrosine before incubation with [ leading to binding of p85␣ and p55 PIK SH2 domains to those phosphotyrosines.
Role of IRS-1 serines in modulating interaction between IRS-1 and PI 3-kinase p55 PIK and p85␣ subunits in the yeast two-hybrid system
In a previous study, we showed that IRS-1 serines 612, 632, 662, and 731 modulate insulin action in intact 293-EBNA cells. Indeed, their mutations resulted in increased IRS-1 tyrosine phosphorylation and association with p85␣, which was correlated with enhanced IRS-1 associated PI 3-kinase activity (8) . The strongest effect was seen with the double mutant S662A/S731A-IRS-1, in which serines 662 and 731 were replaced by alanines. Therefore, we were interested in analyzing the involvement of these serines in the interaction with p85␣ in the yeast two-hybrid system. To do this, GAD-WT-IRS-1 or GAD-S662A/S731A-IRS-1 was coexpressed with LexA-p85␣, and the resulting ␤-galactosidase activity was quantified. As shown in Fig. 4A , S662A/S731A-IRS-1 expression resulted in a 4.5-fold increase in ␤-galactosidase activity compared with WT-IRS-1 when coexpressed with p85␣. This suggests that for binding p85␣, S662A/S731A-IRS-1 was more efficient than the WT protein. Interestingly, we found that when p55 PIK was coexpressed with S662A/ S731A-IRS-1, a 4-fold increase in ␤-galactosidase activity was seen compared with that obtained with wild-type IRS-1. As expected, IRS-1 serine mutations had no effect on IRS-1 interaction with IR ␤-subunit (Fig. 4B) . We also verified that these findings were not due to a difference between WT or S662A/S731A-IRS-1 expression levels (Fig. 4C) .
In summary, we conclude that, for both PI 3-kinase regulatory subunits, p85␣ and p55 PIK , association with IRS-1 is negatively regulated by serines 662 and 731 of the latter molecule.
Roles of IRS-1 serines 662 and 731 in insulin-stimulated PKB activity
We have previously shown in 293-EBNA cells overexpressing S662A/S731A-IRS-1 that insulin-stimulated PI 3-kinase activity is increased compared with WT-IRS-1-overexpressing cells. We actually found that both the insulinstimulated and the basal PI 3-kinase activities are increased about 2-fold with the double serine mutant. To investigate further the effects of these IRS-1 serines on downstream effectors of PI 3-kinase, we wanted to know whether protein kinase B activity is modified in the presence of the double serine mutant compared with WT-IRS-1.
In brief, we overexpressed in 293-EBNA cells WT-PKB with S662A/S731A-IRS-1 or WT-IRS-1; the cells were stimulated or not with insulin before lysis, and the lysates were subjected to immunoprecipitation with antibody to PKB. Finally, a PKB kinase assay on the pellets was performed (Fig.  5) . With S662A/S731A or WT-IRS-1 we found increased stimulation of endogenous PKB. However, after transfection of only PKB, insulin stimulated PKB activity about 4 times more. When PKB and WT-IRS-1 were coexpressed, we observed insulin stimulation of PKB activity that increases to PIK with wild-type IRS-1, IRS-1-F18, and IRS-1-3Y in the yeast two-hybrid system. LexA-p85␣ or LexA-p55 PIK were coexpressed with GAD-IRS-1, GAD-F18-IRS-1, or GAD-3Y-IRS-1 in the presence of L-methionine to suppress IR␤ expression. As control we coexpressed LexA-HIR or LexA-lamin with the different IRS-1 constructs. Clones grown in the appropriate medium were used for ␤-galactosidase assay. Interaction detected by measuring ␤-galactosidase activity is quantitatively shown by a plus; if interaction is absent, it is indicated by a minus. One representative experiment of three is shown.
FIG. 4. Role of IRS-1 serine residues 662 and 731 in its interaction with p85␣ and with p55
PIK . The yeast reporter strain L40 was transformed with pBTM116 plasmid encoding LexA-p85␣ or LexA-p55 PIK (A), or LexA-IR␤ (B) in combination with pACTII plasmid encoding either GAD-IRS-1 or GAD-S662A/S731A-IRS-1. Double transformed cells were grown in liquid culture, and the ␤-galactosidase activity corresponding to each pair of coexpressed hybrid proteins was quantified. The data are the average Ϯ SE of three isolated clones from one independent assay of four. C, Cotransformed yeasts with LexA-p85␣ or LexA-p55 PIK and pACTII encoding GAD, GAD-IRS-1, or GAD-S662A/S731A-IRS-1 were grown in liquid before the cells were frozen and lysed. Then, the lysates were submitted to immunoprecipitation using anti-IRS-1 antibody. Finally, the proteins were resolved by SDS-PAGE, immunoblotted with the same antibody, and incubated with [
125 I]protein A followed by autoradiography.
about 40% compared with PKB alone, whereas cells incubated with buffer did not show any increased PKB activity. When we coexpressed WT-PKB and S6623A/S731A-IRS-1, increased insulin-stimulated PKB activity compared with PKB alone was seen, although the activity is not different from that in WT-IRS-1-and PKB-coexpressing cells. Finally, basal PKB activity was increased about 2 times with the double serine mutant compared with WT-IRS-1. Taking these results together, we conclude that under basal conditions (i.e. without insulin treatment), IRS-1 serines 662 and 731 surrounding tyrosines 658 and 727, which are potential binding sites for PI 3-kinase, are negatively regulating PKB activity. In contrast, those serines do not affect insulin-stimulated PKB activity. 
Discussion
Phosphorylation of IRS-1 on tyrosine residues located in binding motifs for SH2 domain-containing molecules is required for the biological role of IRS-1 as adaptor. Modulation of this key function could be achieved by dephosphorylation of those sites, but also by serine phosphorylation as suggested by several reports (7) (8) (9) (10) . In this study we used yeast two-hybrid analysis to detect, at the molecular level, modulations of p85␣ or p55 PIK binding to IRS-1. We found that both regulatory subunits of PI 3-kinase were able to interact with IRS-1 in the presence as well as the absence of IR␤. At first glance this observation could indicate that IRS-1 can interact with p85␣ in a fashion that does not require tyrosine phosphorylation of IRS-1. However, as IRS-1/PI 3-kinase interaction is known to be dependent on tyrosine phosphorylation, this result would rather suggest that in the absence of IR␤, an endogenous yeast kinase could phosphorylate IRS-1 on tyrosine residues located in YXXM motifs. Importantly, we show that the F18-IRS-1 mutant, lacking 18 potential tyrosine phosphorylation sites, was less efficient than wild-type IRS-1 in binding to p85␣ and p55 PIK . Further, addition to F18-IRS-1 of three tyrosines corresponding to the YXXM motif, which are binding sites for PI 3-kinase (3Y Ϫ IRS-1), resulted in increased association with regulatory subunits of PI 3-kinase compared with that of F18-IRS-1. Taken as a whole, these results suggest that in yeast IRS-1 could be phosphorylated at least in part on tyrosine residues by endogenous yeast kinases. This phosphorylation would probably occur on a few residues, as we failed to reveal IRS-1 phosphorylation in yeast by immunoprecipitating IRS-1 followed by Western blotting with antibodies to phosphotyrosine when IR␤ expression is repressed by l-methionine (not shown). As no classical tyrosine kinases have yet been cloned in yeast, possible candidate kinases for IRS-1 tyrosine phosphorylation are likely to be dual specificity kinases, which would possess activity toward threonine and tyrosine. Indeed, such kinases have actually been identified in yeast (e.g. Wee1) (33) . Those kinases must have the same specificity as IR toward IRS-1, since they phosphorylate PI 3-kinasebinding sites that are crucial for interaction with PI 3-kinase. However, we cannot rule out the possibility that IRS-1 interacts with p85␣ in a phosphotyrosine-independent manner, allowing the p85␣ SH2 domain to bind IRS-1 nonphosphorylated YXXM motifs.
As 3Y-IRS-1 does not fully restore the interaction with p85 compared with WT-IRS-1, some other tyrosine-containing sites on IRS-1 are likely to be phosphorylated and involved in the interaction with p85. When IR␤ is expressed, IRS-1 tyrosine phosphorylation is augmented, leading to increased interaction with the PI 3-kinase regulatory subunit. Together, our results obtained with 3Y-IRS-1 suggest that 1) at least one of the tyrosines, 608, 628, or 658, is phosphorylated; and 2) tyrosine residues other than tyrosines 608, 628, and 658 are involved in the interaction of IRS-1 with p85␣ and p55 PIK in yeast, because with 3Y-IRS-1 the interaction is not completely restored compared with that with WT-IRS-1.
Concerning modulation of IRS-1 interaction with PI 3-kinase, we demonstrate that mutation of IRS-1 serines 662 and 731 to alanine (S662A/S731A-IRS-1) resulted in increased interaction of IRS-1 mutant with p85␣ compared with WT-IRS-1. These serines are adjacent to binding sites for p85␣ (tyrosine 658 and 727 in YMXM motifs) and are potential phosphorylation sites for MAP kinases as they are part of a YMXMSP sequence. Our results extend at the molecular level our previous work in mammalian cells, where we showed increased insulin-induced coimmunoprecipitation of p85␣ with S662A/S731A-IRS-1 compared with wild-type IRS-1 (8) . Moreover, we found in the yeast two-hybrid system that p55 PIK interacted with S662A/S731A-IRS-1 more efficiently than with WT-IRS-1, suggesting that the mutated serine residues are also able to modulate binding of p55 PIK to IRS-1. As mutation of serines 662 and 731 does not affect IR␤ binding to IRS-1, we favor the idea that this regulation is specific for association of regulatory PI 3-kinase subunits with IRS-1. We previously suggested that phosphorylation of serines 662 and 731 by MAP kinases or related kinases could be responsible for the inhibitory effect of these residues on IRS-1 binding to p85␣. Indeed, phosphorylation of these sites would at least partially prevent insulin-induced tyrosine phosphorylation of IRS-1 and/or binding of p85␣ to phosphotyrosinecontaining motifs. Nevertheless, we cannot exclude the possibility that substitution of serine to alanine by itself allows binding of IRS-1 to PI 3-kinase regulatory subunits.
Recently, it has been shown that stimulation of protein kinase C by PMA activates MAP kinase, ERK-2, which is able to phosphorylate a synthetic peptide containing the IRS-1 sequence comprising serine 612; this phosphorylation results in inhibition of IR to further phosphorylate this peptide (12, 13) . This is particularly interesting because the serine residue, which is indeed included in a MAP kinase consensus sequence, YXXMSP, is just upstream tyrosine 608, a recognized PI 3-kinase motif-binding site. Our findings with the IRS-1 serine mutants in yeast suggest that serine-induced negative regulation could occur in this species. Enzymes homologous to mammalian MAP kinases have been cloned in yeast, and they are likely to be able to phosphorylate IRS-1 on serine/ threonine (34) . Further, we revealed phosphoserine on IRS-1 immunopurified from yeast using phosphoserine immunoblotting, indicating that IRS-1 is, in fact, phosphorylated on serine residues in yeast (not shown). Hence, our results show that association of regulatory subunits of PI 3-kinase with IRS-1 in yeast can be negatively regulated by serine mutation to alanine. The fact that we did not detect IRS-1 tyrosine phosphorylation in yeast while not expressing IR␤, although we detected IRS-1 serine phosphorylation, is probably due to the presence of 35 potential serine/threonine phosphorylation sites on IRS-1 compared with 10 putative tyrosine phosphorylation sites, among which 6 are comprised in YMXM. It has been also shown that IRS-1 is heavily phosphorylated on serine under basal conditions compared with tyrosine phosphorylation (8) . Moreover, we can hypothesize that only specific tyrosine residues in the YMXM motif on IRS-1 are phosphorylated by endogenous kinase(s) in yeast, whereas multiple serine sites are phosphorylated.
We further investigated whether serines 662 and 731 that affect the IRS-1 and PI 3-kinase regulatory subunits interactions would provide the same regulation on a downstream effector of PI 3-kinase such as PKB. We show that although serines 662 and 731 of IRS-1 negatively regulate basal and insulin-stimulated PI 3-kinase activities, only basal PKB activity is affected by the double serine mutant. We conclude, therefore, that serines 662 and 731 of IRS-1 negatively regulate PI 3-kinase and PKB activities in resting cells and are involved in PI 3-kinase, but have no impact on PKB activity in insulin-stimulated cells. Phospholipids generated by PI 3-kinase are thought to bind to the PH (pleckstrin homology) domain of PKB, leading to membrane targeting and/or activation of PKB. Moreover, these phospholipids are also involved in activating another protein downstream of PI 3-kinase that is upstream of and directly activates PKB, i.e. phospholipid-dependent kinase-1 (35) . We can hypothesize that under our insulin-stimulated conditions, the increased PI 3-kinase activity seen with the IRS-1 serine mutants that is not correlated with increased PKB activity is due to the fact that above a certain threshold level, an increase in phospholipids does not result in additional activation of phospholipid-dependent kinase-1 and/or PKB. 293 cells pretreated with wortmannin display no or little PKB activity in the presence or absence of IRS-1 (not shown), demonstrating that in these cells, PKB activity relies mostly on PI 3-kinase activity. PKB appears to be involved in key insulin-induced metabolic effects, including glycogen synthesis, glucose transport, and protein synthesis (36) . As evidence has been gathered suggesting that serine phosphorylation is implicated in insulin resistance related to tumor necrosis factor-␣ (10), IRS-1 serine phosphorylation could correspond to a means for regulating key enzymes in insulin signaling, such as PI 3-kinase and/or PKB.
Roth et al. (13) reported that phorbol ester-stimulated protein kinase C activates Erk kinases, which subsequently phosphorylates an IRS-1 peptide containing serine 612. This peptide then becomes less able to be phosphorylated on tyrosine by IRs.
In insulin treated-cells, inhibition of MAP kinases blocked the PMA-induced negative regulation of IRS-1-associated PI 3-kinase activity. Keeping in mind these observations together with ours, we are tempted to speculate that a large number of agents or growth factors, while activating MAP kinases, could at the same time down-regulate insulin signaling for other specific signals delivered into the cell.
In conclusion, our present work provides illustration at the molecular level of the role of serine/threonine phosphorylation of signaling molecules as a mechanism leading to the modulation of insulin action. Whether such a process is operational at the level of the different IRS molecules and impinges on all aspects of the vast repertoire of insulin actions remains to be investigated.
